Rakuten Investment Management Inc. Invests $7.05 Million in Ventas, Inc. $VTR

Rakuten Investment Management Inc. acquired a new stake in Ventas, Inc. (NYSE:VTR) in the second quarter, Holdings Channel reports. The institutional investor acquired 78,903 shares of the real estate investment trust’s stock, valued at approximately $7,046,000.

Several other institutional investors and hedge funds also recently made changes to their positions in VTR. Dynamic Wealth Strategies LLC bought a new stake in Ventas in the first quarter worth $25,000. Wiser Advisor Group LLC purchased a new position in shares of Ventas in the third quarter worth about $27,000. Silvant Capital Management LLC purchased a new position in shares of Ventas in the second quarter worth about $28,000. Meeder Asset Management Inc. bought a new stake in shares of Ventas in the 2nd quarter valued at about $30,000. Finally, IFC & Insurance Marketing Inc. bought a new stake in shares of Ventas in the 4th quarter valued at about $30,000. Institutional investors own 94.18% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on VTR. Jefferies Financial Group raised their price target on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Scotiabank lowered their price objective on Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. The Goldman Sachs Group reissued a “buy” rating and set a $110.00 price objective on shares of Ventas in a research note on Tuesday, May 19th. UBS Group raised their target price on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a report on Monday, May 4th. Finally, Wells Fargo & Company lifted their target price on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.00.

Ventas Trading Down 1.2%

NYSE:VTR opened at $91.78 on Friday. The company has a 50-day moving average price of $92.42 and a 200-day moving average price of $87.57. Ventas, Inc. has a 12 month low of $66.38 and a 12 month high of $101.60. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock has a market cap of $47.08 billion, a price-to-earnings ratio of 169.96, a P/E/G ratio of 2.11 and a beta of 0.69.

Ventas (NYSE:VTR) last announced its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the firm posted $0.87 EPS. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. Equities analysts predict that Ventas, Inc. will post 3.89 EPS for the current year.

Insider Activity at Ventas

In other news, Director Michael J. Embler purchased 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.53% of the stock is currently owned by insiders.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.